What is the treatment for acetaminophen (Tylenol) ingestion toxicity?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Acetaminophen (Tylenol) Overdose

Administer N-acetylcysteine (NAC) immediately to any patient with suspected or confirmed acetaminophen overdose—ideally within 8 hours of ingestion—as this is the only proven antidote that prevents liver failure and reduces mortality. 1

Immediate Initial Management

First Steps (Within Minutes of Presentation)

  • Start NAC immediately without waiting for laboratory results if ≤24 hours have elapsed since ingestion, regardless of the reported amount ingested 2
  • Administer activated charcoal (1 g/kg orally) just prior to starting NAC if the patient presents within 4 hours of ingestion 1, 2
  • Draw blood for acetaminophen level (must be drawn ≥4 hours post-ingestion to be interpretable), baseline AST, ALT, bilirubin, PT/INR, creatinine, BUN, glucose, and electrolytes 2

Critical pitfall: Do not delay NAC while waiting for acetaminophen levels—treatment efficacy is time-dependent and diminishes rapidly after 8 hours 1, 2

NAC Dosing Regimens

Intravenous Protocol (21-hour regimen)

  • Loading dose: 150 mg/kg in 5% dextrose over 15 minutes 1
  • Second dose: 50 mg/kg over 4 hours 1
  • Third dose: 100 mg/kg over 16 hours 1

Oral Protocol (72-hour regimen)

  • Loading dose: 140 mg/kg by mouth or nasogastric tube, diluted to 5% solution 1, 2
  • Maintenance doses: 70 mg/kg every 4 hours for 17 additional doses (total 72 hours) 1, 2
  • If the patient vomits within 1 hour of oral administration, repeat that dose 2

The oral 72-hour regimen is as effective as the IV 20-hour regimen and may be superior when treatment is delayed 1

Risk Stratification Using the Rumack-Matthew Nomogram

When to Use the Nomogram

  • Only applies to: Single acute ingestions with known time of ingestion, when acetaminophen level is drawn 4-24 hours post-ingestion 3, 1
  • Plot the acetaminophen concentration against time since ingestion 1
  • Treat if the level plots at or above the "possible toxicity" line (the lower treatment line) 1, 2

When the Nomogram CANNOT Be Used

The nomogram is invalid and treatment decisions must be based on clinical judgment, acetaminophen levels, and liver function tests in these scenarios:

  • Delayed presentation (>24 hours after ingestion) 3, 1
  • Unknown time of ingestion 3, 1
  • Extended-release acetaminophen formulations 3, 4
  • Repeated supratherapeutic ingestions (multiple doses over >8 hours) 3, 1
  • Ingestion occurred over multiple hours 3

For extended-release formulations, obtain at least two acetaminophen levels 4-6 hours apart, as absorption may continue beyond 8 hours and initial levels may be falsely reassuring 4

Timing and Efficacy: The Critical 8-Hour Window

Treatment Efficacy by Time to NAC Initiation

  • 0-8 hours: Only 2.9% develop severe hepatotoxicity 1
  • 8-10 hours: 6.1% develop severe hepatotoxicity 1
  • 10-24 hours: 26.4% develop severe hepatotoxicity 1
  • 16-24 hours: Among high-risk patients, 41% develop hepatotoxicity (still better than 58% in untreated historical controls) 1

NAC should never be withheld even in late presentations (>24 hours), as it still provides benefit and reduces mortality regardless of time since ingestion 1

Special Clinical Scenarios Requiring Immediate NAC

Mandatory NAC Treatment (Regardless of Nomogram or Timing)

  • Acute liver failure with suspected acetaminophen overdose: Administer NAC immediately, even with inadequate history—reduces mortality from 80% to 52% 1
  • Any elevation in AST or ALT above normal with suspected acetaminophen exposure 1
  • Detectable acetaminophen level with unknown time of ingestion 1
  • Very high aminotransferases (AST/ALT >3,500 IU/L): Highly correlated with acetaminophen poisoning even when history is lacking 1

Repeated Supratherapeutic Ingestions

These represent therapeutic misadventures rather than suicide attempts and require ED referral if: 3, 5

  • ≥10 g or 200 mg/kg (whichever is less) during a single 24-hour period, OR 3, 5
  • ≥6 g or 150 mg/kg (whichever is less) per 24-hour period for ≥48 hours 3, 5
  • For high-risk patients (chronic alcohol use, isoniazid, prolonged fasting): ≥4 g or 100 mg/kg (whichever is less) per day 3, 5

Treat with NAC if serum acetaminophen ≥10 mg/mL OR if AST or ALT >50 IU/L 1

High-Risk Populations Requiring Lower Treatment Threshold

  • Chronic alcohol users: Treat with NAC even with levels in the "non-toxic" range, as severe hepatotoxicity can occur with doses as low as 4-5 g/day 1
  • Patients taking enzyme-inducing drugs (anticonvulsants) or glutathione-depleting conditions (starvation, fasting) 6

When to Stop NAC Therapy

Standard Stopping Criteria (All Must Be Met)

  • Acetaminophen level is undetectable 1
  • AST and ALT remain normal (no elevation above normal) 1
  • No coagulopathy (normal INR) 1
  • Patient presented early and received timely treatment 1

A 12-hour NAC course may be safe in carefully selected low-risk patients with normal labs at presentation and 12 hours, but this requires careful consideration 1

Scenarios Requiring Extended NAC Treatment (Beyond Standard Protocol)

Continue NAC beyond the standard protocol in these situations: 1

  • Delayed presentation (>24 hours post-ingestion)
  • Extended-release acetaminophen
  • Repeated supratherapeutic ingestions
  • Unknown time of ingestion with detectable levels
  • Chronic alcohol use
  • Any elevation in AST or ALT
  • Rising transaminases
  • Any coagulopathy

Red Flags: When to Restart or Continue NAC

NAC must be restarted immediately or continued if: 1

  • Any elevation in AST or ALT above normal
  • Rising transaminases (even if initially normal)
  • Any coagulopathy develops
  • Detectable acetaminophen level persists
  • Clinical signs of hepatotoxicity appear

If severe hepatotoxicity develops (AST/ALT >1,000 IU/L), restart NAC immediately and continue until transaminases are declining and INR normalizes 1

Disposition and Monitoring

ICU-Level Care Required For:

  • Severe hepatotoxicity (AST >1,000 IU/L) 1
  • Any coagulopathy 1
  • Acute liver failure (encephalopathy, elevated bilirubin and INR) 1, 6
  • Contact liver transplant center immediately when there is any evidence of liver failure 1

Daily Monitoring (If Acetaminophen Level in Toxic Range)

  • AST, ALT, bilirubin, PT/INR 2
  • Creatinine, BUN (acute renal failure occurs in <2% of all overdoses but 10% of severe poisonings) 6
  • Glucose, electrolytes 2

Common Pitfalls to Avoid

  • Do not wait for acetaminophen levels before starting NAC—treatment must begin immediately if ≤24 hours since ingestion 2
  • Do not rely on patient-reported ingestion amount—history is often inaccurate 2
  • Do not use a single 4-hour level for extended-release formulations—obtain serial levels 4
  • Do not stop NAC prematurely—any transaminase elevation mandates continuation 1
  • Low or absent acetaminophen levels do NOT rule out toxicity if ingestion was remote or occurred over several days 1
  • Patients may present with elevated transaminases despite "no risk" nomogram placement due to inaccurate history or increased susceptibility 1

References

Guideline

Acetaminophen Overdose Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Tylenol Extended Relief overdose.

Annals of emergency medicine, 1997

Research

Acute renal failure due to acetaminophen ingestion: a case report and review of the literature.

Journal of the American Society of Nephrology : JASN, 1995

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.